Ludwig Cancer Research is a global community of leading scientists pursuing innovative ways to prevent and control cancer. From basic research to clinical trials, in individual laboratories or as part of international teams, our researchers are tackling the hardest questions, spotting the connections and the possibilities. At Ludwig, we test our work against the one measure that matters — improving human health. Ludwig Cancer Research is a global community of leading scientists pursuing innovative ways to prevent and control cancer. From basic research to clinical trials, in individual laboratories or as part of international teams, our researchers are tackling the hardest questions, spotting the connections and the possibilities. At Ludwig, we test our work against the one measure that matters — improving human health.

I have been Director of the Ludwig Institute in Uppsala since 1986. I'm also a professor of Molecular Cell Biology at Uppsala University. I was born in 1952, and obtained a PhD in Medical and Physiological Chemistry in 1980 at the University of Uppsala, where I continued to work until 1985 in a position sponsored by the Swedish Cancer Society. I am an elected member of the European Molecular Biology Organization (1989), Royal Swedish Academy of Sciences (1991), Royal Scientific Society (Uppsala; 1995), Academia Europea (1999), Japanese Association for Cancer Research (2002), Finnish Scientific Society (2006), ScanBalt Academy (2006), Hellenic Biochemical Society (2007), Norwegian Academy of Sciences and Letters (2009) and European Academy of Cancer Sciences (2009). I am Doctor honoris causa at the universities of Patras (2009), Helsinki (2010), Turku (2011) and Heidelberg (2011). I have served on the Scientific Advisory Boards for several companies and academic institutions, including the European Molecular Biology Organization, Heidelberg; the German Cancer Center, Heidelberg; and the Max Planck Institute for Biochemistry, Martinsried; and now serve on the Scientific Advisory Boards for the European Institute for Oncology, Milan; Biotechnology Center, Oslo; Center for Molecular Medicine, Vienna; and the Finnish Institute for Molecular Medicine, Helsinki. I have served on the Board of the Swedish Research Council, and am  Vice President of the European Research Council and the Chair of the Board of the Nobel Foundation. I also serve as Associate Editor for Molecular Biology of the Cell, Genes to Cells and Growth Factors. I have published 394 research articles and 195 review articles, and have 26 approved patents. My work has been cited  more than 55,000 times. My H‑index is 128.